Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare genetic disorders of obesity, has reported an insider sell according to a recent SEC filing.
Related Keywords
, Biopharmaceutical Company , Rhythm Pharmaceuticals Inc , Fec Filing , Joseph Shulman , Rare Genetic Disorders , Nsider Transaction ,
vimarsana.com © 2020. All Rights Reserved.